Emerging data presented at ENDO 2025 on July 14 reveal that GLP‑1 receptor agonists—widely used for diabetes and obesity—may offer a new avenue to boost testosterone in men, marking a breakthrough …
Copyright @2025 MensNewspaper || All Rights Reserved. Design by RINKU